T-Type Calcium Channels as Potential Therapeutic Targets in Vemurafenib-Resistant BRAFV600E Melanoma.
Barceló C, Sisó P, Maiques O, García-Mulero S, Sanz-Pamplona R, Navaridas R, Megino C, Felip I, Urdanibia I, Eritja N, Soria X, Piulats JM, Penin RM, Dolcet X, Matías-Guiu X, Martí RM, Macià A.
Barceló C, et al. Among authors: soria x.
J Invest Dermatol. 2020 Jun;140(6):1253-1265. doi: 10.1016/j.jid.2019.11.014. Epub 2019 Dec 23.
J Invest Dermatol. 2020.
PMID: 31877318
Free article.